Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines Chirag ShahPat WhitworthFrank A. Vicini Review Open access 24 December 2022 Pages: 1 - 9
Assessing the role of tumour-associated macrophage subsets in breast cancer subtypes using digital image analysis Mieke C. ZwagerRico BenseBert van der Vegt Preclinical study Open access 09 January 2023 Pages: 11 - 22
A propensity score–weighted study comparing a two- versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer H. BischoffC. BigotP. Trensz Clinical Trial 23 December 2022 Pages: 23 - 29
Preventing metastatic recurrence in low-risk ER/PR + breast cancer patients—a retrospective clinical study exploring the evolving challenge of persistence with adjuvant endocrine therapy Elaine P. KuhnJonathan PirruccelloMary D. Chamberlin Clinical Trial Open access 02 January 2023 Pages: 31 - 41
Early effectiveness and toxicity outcomes of reirradiation after breast conserving surgery for recurrent or new primary breast cancer Camille Hardy-AbeloosJulie XiaoNaamit Gerber Clinical trial 05 January 2023 Pages: 43 - 51
Pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis and treatment outcomes with non-pregnant patients Qing Ting TanVeronica Siton AlcantaraFuh Yong Wong Clinical trial 08 January 2023 Pages: 53 - 66
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer Matthew LoftSheau Wen LokLucy Gately Clinical trial 09 January 2023 Pages: 67 - 74
Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2-negative metastatic breast cancer Alvaro AlvarezAna M. BernalJesus Anampa Epidemiology 23 December 2022 Pages: 75 - 88
A retrospective study in tumour characteristics and clinical outcomes of overweight and obese women with breast cancer Carla LuísJoão DiasRaquel Soares Epidemiology Open access 28 December 2022 Pages: 89 - 101
Adjuvant chemotherapy in patients with ER-negative/HER2-negative, T1abN0 breast cancer: a nationwide study Christina M. S. HassingMathias Kvist MejdahlTove Holst Filtenborg Tvedskov Epidemiology 28 December 2022 Pages: 103 - 112
The association of trastuzumab with atrial fibrillation and heart failure in breast cancer patients in routine clinical practice: a population-based propensity score matching and competing risk model analysis Wen-Chi WuChi-Cheng HuangLing-Ming Tseng Epidemiology Open access 31 December 2022 Pages: 113 - 122
Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III Study (GBECAM 0115) Raíra Mesquita MaschmannRafaela Gomes De JesusDaniela Dornelles Rosa Epidemiology 31 December 2022 Pages: 123 - 130
Clinical impact of MRI-detected additional lesions in breast cancer patients with neoadjuvant systemic therapy at the Netherlands cancer institute Ariane A. van LoevezijnHillegonda A. O. Winter-WarnarsMarie-Jeanne T. F. D. Vrancken Peeters Epidemiology 02 January 2023 Pages: 131 - 141
Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in situ hybridization Aswin ShanmugalingamKerry HitosNicholas K. Ngui Epidemiology 05 January 2023 Pages: 143 - 148
Disparities in the use of assisted reproductive technologies after breast cancer: a population-based study Clare MeernikKirsten JorgensenJ. Alejandro Rauh-Hain Epidemiology 06 January 2023 Pages: 149 - 158
Impact of CDK4/6 inhibitors on chemotherapy utilization in earlier therapy lines for HR+/HER2– metastatic breast cancer in the United States Ravi K. GoyalHolly M. HolmesMichael L. Johnson Epidemiology 07 January 2023 Pages: 159 - 166
Association between patient–surgeon race and gender concordance and patient-reported outcomes following breast cancer surgery Abbas M. HassanSuvethavarshini KetheeswaranAnaeze C. Offodile 2nd Epidemiology 09 January 2023 Pages: 167 - 175
Genetic testing in privately insured women with surgically treated breast cancer Michaela A. DinanSarah PitafiCary P. Gross Brief Communication 21 December 2022 Pages: 177 - 181
Possible mechanism behind the association between disrupted sleep quality and breast cancer outcome Kadri Altundag Letter to the Editor 05 January 2023 Pages: 183 - 183
A rare but persistent cause of decreased function secondary to adjuvant radiation therapy in women with breast cancer Susan R. Harris Letter to the Editor 05 January 2023 Pages: 185 - 186
